Synthetic Biology and Active Pharmaceutical Ingredients Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Synthetic Biology and Active Pharmaceutical Ingredients Act
This bill requires the Department of Defense (DOD) to establish a pilot program to support domestic manufacturing of critical pharmaceutical ingredients and their components through certain novel technology.
Specifically, DOD must establish a three-year program that uses technology involving synthetic biology to support domestic manufacturing of pharmaceutical ingredients and related incorporated materials that (1) are not available in a sufficient quantity or quality domestically, and (2) are strategically important to the United States.
Referred to the House Committee on Armed Services.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 6897: Synthetic Biology and Active Pharmaceutical Ingredients Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-6897/
"H.R. 6897: Synthetic Biology and Active Pharmaceutical Ingredients Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-6897/.
H.R. 6897, 118th Cong. (2026), https://openamerica.io/bill/118-HR-6897/.
[H.R. 6897: Synthetic Biology and Active Pharmaceutical Ingredients Act](https://openamerica.io/bill/118-HR-6897/)